The National Vaccine Committee has approved the national vaccine security strategy and agreed to push for the inclusion of ...
"We observed wide variation across pneumococcal conjugate vaccine (PCV) products in serotype coverage and potentially preventable burdens. Variation in both invasive and mucosal disease coverage and ...
An announcement from CanSino Biologics, Inc. Class H ( ($HK:6185) ) is now available. CanSino Biologics Inc. has received approval from China’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback